跳至主要内容
临床试验/ACTRN12619001227189
ACTRN12619001227189
已完成
2 期

A randomized, open-label trial non-inferiority study of bicarbonate buffered solution vs Plasmalyte solution fluid therapy during adult liver transplantation

Professor Rinaldo Bellomo0 个研究点目标入组 52 人2019年9月5日

概览

阶段
2 期
干预措施
未指定
疾病 / 适应症
iver transplantation
发起方
Professor Rinaldo Bellomo
入组人数
52
状态
已完成
最后更新
3年前

概览

简要总结

暂无简介。

注册库
who.int
开始日期
2019年9月5日
结束日期
2022年7月31日
最后更新
3年前
研究类型
Interventional
性别
All

研究者

发起方
Professor Rinaldo Bellomo

入排标准

入选标准

  • Adult liver donor recipients aged 18 years or older
  • Primary deceased donor liver transplantation including donation after brain death and donation after cardiac death
  • Redo deceased donor liver transplantation

排除标准

  • Paediatric recipients aged 17 years of less
  • Combined liver\-kidney transplant
  • Combined liver\-small bowel transplant
  • Fulminant hepatic failure
  • End stage renal disease defined as a serum creatinine greater than 300 micromol per litre

结局指标

主要结局

未指定

相似试验

招募中
4 期
A Randomized, Open label, Non-inferiority trial on the efficacy of Lacosamide versus Duloxetine in Patients with Chemotherapy-induced Polyneuropathy - a strategy trialChemotherapy-induced polyneuropathynerve pain10034606
NL-OMON52883eids Universitair Medisch Centrum110
进行中(未招募)
1 期
A Randomized, open label, Non-inferiority trial on the efficacy of Lacosamide versus Duloxetine in Patients with Chemotherapy-induced Polyneuropathy – A strategy trial
EUCTR2020-001285-11-NLeiden University Medical Center100
进行中(未招募)
1 期
An open label, randomised, non-inferiority trial of pegylated interferon, ribavirin and telaprevir versus pegylated interferon and ribavirin alone in the response guided treatment of acute hepatitis C genotype 1 virus infection in patients with HIV-1 co-infection: The CHAT Study
EUCTR2012-001419-21-DEniversitätsklinikum Bonn40
进行中(未招募)
不适用
Randomised, controlled open label trial to compare the efficacy safety and tolerability of a treatment simplification by darunavir/ritonavir DRV/r 800/100 mg OD vs a triple combination therapy containing DRV/r in HIV-1 infected subjects with undetectable plasma HIV-1 RNA on their current treatments - TMC114HIV3006HIV-1 patients with plasma RNA HIV-1 undetectable in current treatmentMedDRA version: 9.1Level: LLTClassification code 10049829Term: Blood HIV RNA below assay limit
EUCTR2006-006437-40-ITJANSSEN-CILAG INTERNATIONAL N.V.250
进行中(未招募)
1 期
Clinical study aimed to compare tocilizumab to anti-TNF treatment and to discover biomarkers for treatment selection in rheumatoid arthritis patients with inadequate response to a first anti-TNFRHEUMATOID ARTHRITISMedDRA version: 20.0Level: LLTClassification code 10037738Term: R arthritisSystem Organ Class: 10028395 - Musculoskeletal and connective tissue disordersMedDRA version: 23.1Level: PTClassification code 10039073Term: Rheumatoid arthritisSystem Organ Class: 10028395 - Musculoskeletal and connective tissue disordersMedDRA version: 20.0Level: LLTClassification code 10039014Term: Rh arthritisSystem Organ Class: 10028395 - Musculoskeletal and connective tissue disordersMedDRA version: 23.1Level: LLTClassification code 10003268Term: Arthritis rheumatoidSystem Organ Class: 10028395 - Musculoskeletal and connective tissue disordersTherapeutic area: Diseases [C] - Musculoskeletal Diseases [C05]
EUCTR2016-001987-12-ITSOCIETA' ITALIANA DI REUMATOLOGIA - SIR208